|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Watson AJ and Collins PD: Colon cancer: A
civilization disorder. Dig Dis. 29:222–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wilusz JE: Long noncoding RNAs: Re-writing
dogmas of RNA processing and stability. Biochim Biophys Acta.
1859:128–138. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun M, Nie F, Wang Y, Zhang Z, Hou J, He
D, Xie M, Xu L, De W, Wang Z and Wang J: LncRNA HOXA11-AS Promotes
Proliferation and Invasion of Gastric Cancer by Scaffolding the
Chromatin Modification Factors PRC2, LSD1, and DNMT1. Cancer Res.
76:1–6310. 2016. View Article : Google Scholar
|
|
5
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR and
Goel A: Metastasis-associated long non-coding RNA drives gastric
cancer development and promotes peritoneal metastasis.
Carcinogenesis. 35:1–2739. 2014. View Article : Google Scholar
|
|
6
|
Xia H and Hui KM: Mechanism of cancer drug
resistance and the involvement of noncoding RNAs. Curr Med Chem.
21:3029–3041. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo HL, Huang MD, Guo JN, Fan RH, Xia XT,
He JD and Chen XF: AFAP1-AS1 is upregulated and promotes esophageal
squamous cell carcinoma cell proliferation and inhibits cell
apoptosis. Cancer Med. 5:1–2885. 2016. View
Article : Google Scholar
|
|
8
|
Xue M, Chen W and Li X: Urothelial cancer
associated 1: A long noncoding RNA with a crucial role in cancer. J
Cancer Res Clin Oncol. 142:1407–1419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Young TL, Matsuda T and Cepko CL: The
noncoding RNA taurine upregulated gene 1 is required for
differentiation of the murine retina. Curr Biol. 15:1–512. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW,
Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, et al: Rapid identification
of TUG1 as a very sensitive and specific unique marker for human
bladder carcinoma. Clin Cancer Res. 12:4851–4858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: Long non-coding RNA TUG1 increases chemoresistance of
bladder cancer cells by regulating Wnt signaling. FEBS J.
281:1750–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tan J, Qiu K, Li M and Liang Y:
Double-negative feedback loop between long non-coding RNA TUG1 and
miR-145 promotes epithelial to mesenchymal transition and
radioresistance in human bladder cancer cells. FEBS Lett.
589:3175–3181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tuo YL, Li XM and Luo J: Long noncoding
RNA TUG1 modulates colorectal cancer cell growth and apoptosis
through decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol
Sci. 19:3403–3411. 2015.PubMed/NCBI
|
|
14
|
Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu
M and Mo YY: Long non-coding RNA TUG1 promotes colorectal tumor
growth by suppression of p27 (Kip1). Cell Death Dis. 5:e10082014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:1–2315. 2013.PubMed/NCBI
|
|
17
|
Isin M, Ozgur E, Cetin G, Erten N, Aktan
M, Gezer U and Dalay N: Investigation of circulating lncRNAs in
B-cell neoplasms. Clin Chim Acta. 431:1–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu Y, Wang J, Qiu M and Xu L, Li M, Jiang
F, Yin R and Xu L: Upregulation of the long noncoding RNA TUG1
promotes proliferation and migration of esophageal squamous cell
carcinoma. Tumour Biol. 36:1–1651. 2015.
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:1–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, . Guide for the Care and Use of Laboratory Animals. 8th.
Washington, DC: National Academies Press (US); 2011, PubMed/NCBI
|
|
21
|
Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L,
Sun J, Cai J, Qin J, Ren J and Li Q: Resveratrol Inhibits invasion
and metastasis of colorectal cancer cells via MALAT1 mediated
Wnt/β-catenin signal pathway. PLoS One. 8:e787002013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Venook AP: Advances in Adjuvant Therapy
for Colon Cancer: P value or Practical Value. J Clin Oncol.
36:1–1462. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gezer U, Ozgur E, Cetinkaya M, Isin M and
Dalay N: Long noncoding RNAs with low expression levels in cells
are enriched in secreted exosomes. Cell Biol Int. 38:1–1079.
2014.PubMed/NCBI
|
|
24
|
Li ZR, Wu YF, Ma CY, Nie SD, Mao XH and
Shi YZ: Down-regulation of c-Myc expression inhibits the invasion
of bile duct carcinoma cells. Cell Biol Int. 35:799–802. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Gill AJ, Issacs JD, Atmore B,
Johns A, Delbridge LW, Lai R and McMullen TP: The Wnt/β-catenin
pathway drives increased cyclin D1 levels in lymph node metastasis
in papillary thyroid cancer. Hum Pathol. 43:1044–1050. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Villar J, Cabrera NE, Valladares F, Casula
M, Flores C, Blanch L, Quilez ME, Santana-Rodríguez N, Kacmarek RM
and Slutsky AS: Activation of the Wnt/β-Catenin signaling pathway
by mechanical ventilation is associated with ventilator-induced
pulmonary fibrosis in healthy lungs. PLoS One. 6:e239142011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zeilstra J, Joosten SP, Dokter M, Verwiel
E, Spaargaren M and Pals ST: Deletion of the WNT target and cancer
stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal
tumorigenesis. Cancer Res. 68:3655–3661. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brantjes H, Barker N, van Es J and Clevers
H: TCF: Lady Justice casting the final verdict on the outcome of
Wnt signalling. Biol Chem. 383:1–261. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Brabletz T, Jung A, Reu S, Porzner M,
Hlubek F, Kunz-Schughart LA, Knuechel R and Kirchner T: Variable
betacatenin expression in colorectal cancers indicates tumor
progression driven by the tumor environment. Proc Natl Acad Sci
USA. 98:1–10361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hlubek F, Brabletz T, Budczies J, Pfeiffer
S, Jung A and Kirchner T: Heterogeneous expression of
Wnt/beta-catenin target genes within colorectal cancer. Int J
Cancer. 121:1–1948. 2007. View Article : Google Scholar : PubMed/NCBI
|
